10x Genomics, Inc. (TXG)
NASDAQ: TXG · Real-Time Price · USD
24.83
+1.25 (5.30%)
Apr 14, 2026, 3:50 PM EDT - Market open
10x Genomics Revenue
In the year 2025, 10x Genomics had annual revenue of $642.82M with 5.25% growth. 10x Genomics had revenue of $166.03M in the quarter ending December 31, 2025, with 0.61% growth.
Revenue (ttm)
$642.82M
Revenue Growth
+5.25%
P/S Ratio
5.00
Revenue / Employee
$545,690
Employees
1,178
Market Cap
3.17B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 642.82M | 32.04M | 5.25% |
| Dec 31, 2024 | 610.79M | -7.94M | -1.28% |
| Dec 31, 2023 | 618.73M | 102.32M | 19.81% |
| Dec 31, 2022 | 516.41M | 25.92M | 5.28% |
| Dec 31, 2021 | 490.49M | 191.65M | 64.13% |
| Dec 31, 2020 | 298.85M | 52.95M | 21.53% |
| Dec 31, 2019 | 245.89M | 99.58M | 68.06% |
| Dec 31, 2018 | 146.31M | 75.23M | 105.83% |
| Dec 31, 2017 | 71.09M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BrightSpring Health Services | 12.91B |
| Teladoc Health | 2.53B |
| Privia Health Group | 2.12B |
| HealthEquity | 1.31B |
| Tempus AI | 1.27B |
| Omnicell | 1.18B |
| Waystar Holding | 1.10B |
| Doximity | 637.78M |
TXG News
- 14 days ago - 10x Genomics Seen As Key Player In AI-Driven Biological Data Buildout - Benzinga
- 20 days ago - Bioptimus Announces STELA: The World's Largest Clinically Linked Spatial Biology Atlas, alongside key partners 10x Genomics and Broad Clinical Labs - PRNewsWire
- 4 weeks ago - PerturbAI Launches from Stealth, Unveils the World's Largest In Vivo CRISPR Atlas - PRNewsWire
- 7 weeks ago - 10x Genomics to Participate in the 46th Annual TD Cowen Health Care Conference - PRNewsWire
- 2 months ago - 10x Genomics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Outlook for 2026 - PRNewsWire
- 2 months ago - PharosAI and 10x Genomics Partner to Transform Cancer Research with AI and Spatial Biology - PRNewsWire
- 2 months ago - 10x Genomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026 - PRNewsWire
- 3 months ago - 10x Genomics Launches Study to Advance Research in Blood-Based Diagnostics for Autoimmune Disease - PRNewsWire